Australia markets open in 7 hours 7 minutes

Atea Pharmaceuticals, Inc. (AVIR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
11.92-0.47 (-3.79%)
As of 11:52AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close12.39
Open12.37
Bid11.93 x 1100
Ask11.94 x 900
Day's range11.91 - 12.51
52-week range10.76 - 94.17
Volume1,149,758
Avg. volume4,276,367
Market cap986.701M
Beta (5Y monthly)N/A
PE ratio (TTM)20.73
EPS (TTM)0.57
Earnings date12 Aug 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est16.67
  • Motley Fool

    3 Top COVID Stocks -- Are They Tricks or Treats?

    Taylor Carmichael (Novavax): Novavax's COVID-19 vaccine is still not on the market anywhere, which has made the stock a real wild ride for investors. The vaccine specialist started off 2020 so small it almost qualified as a micro-cap, with its stock priced at $4 a share. When COVID-19 hit, however, the stock took off.

  • Motley Fool

    Was Atea Pharmaceutical's Flop Predictable?

    This month, as Merck (NYSE: MRK) moves forward with an Emergency Use Authorization in the U.S. for its oral antiviral for COVID-19, Atea Pharmaceuticals (NASDAQ: AVIR) stock saw a significant drop. Unfortunately, investors are unlikely to see the small-cap biotech replicate Moderna's success as the next COVID-19 underdog success story after news of its negative clinical trial. Let's explore what caused Atea's drop and how biotech investors should examine their future investments.

  • Motley Fool

    Are Atea Pharmaceuticals, Agenus, Novavax, and Ocular Therapeutix Bad News Buy?

    Biotech stocks are in a slump. Despite numerous wins in the high-profile areas of COVID-19 and cancer therapy, the industry has failed to excite investors this year -- as seen in the 12% year-to-date fall in the the bellwether SPDR S&P Biotech ETF. Risk-tolerant growth investors appear to be favoring other vehicles over biotech in 2021, such as the red-hot cryptocurrency Shiba Inu (CRYPTO: SHIB), electric-vehicle giant Tesla (NASDAQ: TSLA), and emerging social media plays such as Digital World Acquisition (NASDAQ: DWAC) and Phunware (NASDAQ: PHUN).